# Mortality burden of malignant neoplasms of the corpus uteri in Mexico: an analysis of trends from 2000 to 2022

**Authors:** Eugenia Flores-Alfaro, Felipe Adrián Encarnación-López, Gabriela Elizabeth Campos-Viguri, Maria Elena Moreno-Godínez, Ana Karen Herrera-Vargas, Marco Antonio Ramírez-Vargas

PMC · DOI: 10.1590/1980-549720260001 · Revista Brasileira de Epidemiologia (Brazilian Journal of Epidemiology) · 2026-01-30

## TL;DR

This study examines the rising mortality rate of uterine cancer in Mexico from 2000 to 2022, highlighting the need for better prevention and early diagnosis.

## Contribution

The study provides new insights into the increasing mortality trends of uterine cancer in Mexico over two decades.

## Key findings

- The age-standardized mortality rate for uterine cancer was 2.5 (95% CI 2.2–2.8).
- The annual percentage change in mortality rate from 2000 to 2018 was 4.32%.
- Women aged 60–65 years were most affected by the mortality increase.

## Abstract

The aim of this study was to analyze temporal trends in malignant neoplasms of corpus uteri mortality in México from 2000 through 2022.

Certificates of death were analyzed. The age-standardized mortality rate (ASMR), the number of years of life lost, according to the federal state, was estimated. The changes in temporal trends were analyzed using joint point regression.

The ASMR from malignant neoplasms of the corpus uteri was estimated at 2.5 (95% confidence interval [CI] 2.2–2.8), and the annual percentage change from 2000 to 2018 was 4.32. The age group of 60–65 years was most affected.

This report indicates an increase in the ASMR from malignant neoplasms of the corpus uteri. It also suggests the need for the development of public health laws focusing on the early diagnosis and prevention of uterine cancer.

## Linked entities

- **Diseases:** uterine cancer (MONDO:0002715)

## Full-text entities

- **Diseases:** uterine cancer (MESH:D014594), death (MESH:D003643), malignant neoplasms (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12858089/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12858089/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12858089/full.md

---
Source: https://tomesphere.com/paper/PMC12858089